cardiac remodeling after myocardial infarction (MI) is a maladaptive changes associated with progressive heart failure and compromise the long-term clinical outcomes. Most of the patients afflicted by MI still developing adverse outcomes associated with cardiac remodeling. Therefore, it is important to identify biomarkers for early prediction of cardiac remodeling. An in-depth proteomic approaches, including both an array of semi-quantitative and quantitative antibody, is used to identify circulating biomarkers that may be associated with adverse cardiac remodeling.
Furthermore, the statistical correlation analysis was conducted between biomarker candidates and clinical cardiac remodeling the data to demonstrate their clinical utility. A proteomics systematic approach revealed that sclerostin (SOST), differentiation of growth factor-15 (GDF-15), urokinase-type plasminogen activator (uPA) and midkine (MK) increases, while monocytes chemotactic protein – 3 (MCP- 3 ) is a unique decreased in patients who develop cardiac remodeling MI, compared with patients with MI not develop cardiac remodeling and healthy humen.
In addition, the analysis of the correlation between the proteomes of serum and cardiac remodeling parameters of echocardiography showed a positive relationship moderate between left ventricular indexes end-diastolic volume (LVEDVi) and three serum protein , uPA, MK and GDF-15 (P <0 , 05, respectively), and moderate negative correlation between LV ejection fraction (LVEF) and serum is protein (P <0.05, respectively). Importantly, uPA and MK were first identified associated with the development of cardiac remodeling. The research contributes to a better understanding of various cytokines expressed during adverse cardiac remodeling. biomarkers identified could facilitate the early identification of patients at high risk for ischemic heart failure awaiting further confirmation through larger clinical trials.
Prevention of severe intestinal dysfunction Through Barrier Single-Species Probiotic Is Associated With Microbiome-Mediated Activation of Glutamate-Glutamine Biosynthesis Introduction: Intra-abdominal hypertension (IAH), the leading complications in the intensive care unit, significantly disrupt the intestinal microbial composition by reducing the relative abundance of Lactobacillus and increasing the relative abundance of opportunistic infectious bacteria.
Method: In order to evaluate the preventive effect of probiotic-based Lactobacillus at IAH-induced damage intestinal barrier, a-single species of probiotics (L92) and multi-species probiotics (VSL # 3 ) is introduced orally to rats Sprague-Dawley 7 days before inducing IAH. Histology intestine and permeability to macromolecules (isothiocyanate fluoresceine, FITC-dextran, N = 8 for each group), parameter immunomodulatory and response to oxidative [ monocytes chemotactic protein 1 (MCP-1), interleukin-1β (IL-1β), interleukin-4 (IL-4), interleukin-10 (IL-10), malonaldehyde (MDA), glutathione peroxidase (GSH- Px), catalase (CAT) and superoxide dismutase (SOD); N = 4 for each group], and profiling microbiome (N = 4 per group) were analyzed.
(S)-MCPG |
|||
| B6266-5 | ApexBio | 5 mg | EUR 106 |
|
Description: mGluR antagonist |
|||
(S)-MCPG |
|||
| B6266-50 | ApexBio | 50mg | EUR 523 |
|
Description: mGluR antagonist |
|||
(RS)-MCPG |
|||
| 555671 | MedKoo Biosciences | 100.0mg | EUR 950 |
(RS)-MCPG |
|||
| HY-100371 | MedChemExpress | 100mg | EUR 1135.2 |
(S)-MCPG |
|||
| HY-100406 | MedChemExpress | 5mg | EUR 159.6 |
(S)-MCPG |
|||
| M199718 | Toronto Research Chemicals | 1g | EUR 7600 |
|
Description: 150145-89-4 |
|||
(RS)-MCPG |
|||
| M264743 | Toronto Research Chemicals | 100mg | EUR 3000 |
|
Description: 146669-29-6 |
|||
(RS)-MCPG |
|||
| T3479-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (RS)-MCPG |
|||
(RS)-MCPG |
|||
| T3479-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (RS)-MCPG |
|||
(RS)-MCPG |
|||
| T3479-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (RS)-MCPG |
|||
(RS)-MCPG |
|||
| T3479-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (RS)-MCPG |
|||
(RS)-MCPG |
|||
| T3479-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (RS)-MCPG |
|||
(S)-MCPG |
|||
| T13452-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (S)-MCPG |
|||
(S)-MCPG |
|||
| T13452-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (S)-MCPG |
|||
(S)-MCPG |
|||
| T13452-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (S)-MCPG |
|||
(S)-MCPG |
|||
| T13452-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (S)-MCPG |
|||
(S)-MCPG |
|||
| T13452-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (S)-MCPG |
|||
(RS)-MCPG |
|||
| MBS579609-10mg | MyBiosource | 10mg | EUR 180 |
(RS)-MCPG |
|||
| MBS579609-25mg | MyBiosource | 25mg | EUR 275 |
(RS)-MCPG |
|||
| MBS579609-2mg | MyBiosource | 2mg | EUR 145 |
(RS)-MCPG |
|||
| MBS579609-50mg | MyBiosource | 50mg | EUR 410 |
(RS)-MCPG |
|||
| MBS579609-5mg | MyBiosource | 5mg | EUR 160 |
(S)-MCPG |
|||
| MBS3844992-100mg | MyBiosource | 100mg | EUR 825 |
(S)-MCPG |
|||
| MBS3844992-10mg | MyBiosource | 10mg | EUR 200 |
(S)-MCPG |
|||
| MBS3844992-50mg | MyBiosource | 50mg | EUR 440 |
(S)-MCPG |
|||
| MBS3844992-5mg | MyBiosource | 5mg | EUR 155 |
(S)-MCPG |
|||
| MBS3844992-5x100mg | MyBiosource | 5x100mg | EUR 3695 |
(RS)-MCPG |
|||
| MBS3845259-100mg | MyBiosource | 100mg | EUR 910 |
(RS)-MCPG |
|||
| MBS3845259-10mg | MyBiosource | 10mg | EUR 210 |
(RS)-MCPG |
|||
| MBS3845259-50mg | MyBiosource | 50mg | EUR 485 |
(RS)-MCPG |
|||
| MBS3845259-5mg | MyBiosource | 5mg | EUR 165 |
(RS)-MCPG |
|||
| MBS3845259-5x100mg | MyBiosource | 5x100mg | EUR 4085 |
(RS)-MCPG |
|||
| MBS3607307-10mg | MyBiosource | 10mg | EUR 245 |
(RS)-MCPG |
|||
| MBS3607307-25mg | MyBiosource | 25mg | EUR 340 |
(RS)-MCPG |
|||
| MBS3607307-2mg | MyBiosource | 2mg | EUR 200 |
(RS)-MCPG |
|||
| MBS3607307-50mg | MyBiosource | 50mg | EUR 475 |
(RS)-MCPG |
|||
| MBS3607307-5mg | MyBiosource | 5mg | EUR 220 |
(S)-MCPG |
|||
| MBS5754201-200mg | MyBiosource | 200mg | EUR 1055 |
(S)-MCPG |
|||
| MBS5754201-5x200mg | MyBiosource | 5x200mg | EUR 4610 |
MCPG (sodium) |
|||
| HY-103570 | MedChemExpress | Get quote | Ask for price |
|
Description: MCPG is a carboxylic phenyl glycine. MCPG can block metabotropic glutamate receptor (mGluR)(HY-15129) and has antagonistic activity of mGluR subtype. MCPG can be used to study the induction and maintenance of long-term potentiation (LTP) [1]. |
|||
(RS)-MCPG disodium salt |
|||
| B7476-10 | ApexBio | 10 mg | EUR 126 |
|
Description: group I/group II metabotropic glutamate receptor antagonist |
|||
(RS)-MCPG disodium salt |
|||
| B7476-100 | ApexBio | 100mg | EUR 900 |
|
Description: group I/group II metabotropic glutamate receptor antagonist |
|||
(RS)-MCPG disodium salt |
|||
| B7476-25 | ApexBio | 25mg | EUR 278 |
|
Description: group I/group II metabotropic glutamate receptor antagonist |
|||
(RS)-MCPG disodium salt |
|||
| B7476-5 | ApexBio | 5mg | EUR 91 |
|
Description: group I/group II metabotropic glutamate receptor antagonist |
|||
(RS)-MCPG disodium salt |
|||
| B7476-50 | ApexBio | 50 mg | EUR 490 |
|
Description: group I/group II metabotropic glutamate receptor antagonist |
|||
(RS)-MCPG disodium salt |
|||
| T23270-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (RS)-MCPG disodium salt |
|||
(RS)-MCPG disodium salt |
|||
| T23270-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (RS)-MCPG disodium salt |
|||
(RS)-MCPG disodium salt |
|||
| T23270-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (RS)-MCPG disodium salt |
|||
(RS)-MCPG disodium salt |
|||
| T23270-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (RS)-MCPG disodium salt |
|||
(RS)-MCPG disodium salt |
|||
| T23270-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (RS)-MCPG disodium salt |
|||
(RS)-MCPG disodium salt |
|||
| MBS5757736-50mg | MyBiosource | 50mg | EUR 1140 |
(RS)-MCPG disodium salt |
|||
| MBS5757736-5x50mg | MyBiosource | 5x50mg | EUR 4970 |
Avidin 50mg |
|||
| IB2-0204-050 | Westburg | each | EUR 274.68 |
Mitomycin C, 50mg |
|||
| R5007 | ACTGene | 50mg | EUR 1190.08 |
Mitomycin C, 50mg |
|||
| R5007-50mg | ACTGene | each | EUR 1712.4 |
Gentamicin, 50mg/ml |
|||
| CA003-001 | GenDepot | 10ml | EUR 109.2 |
Kanamycin (50mg/ml, 1000X) |
|||
| K2802-10 | ApexBio | 10x1ml | EUR 64 |
|
Description: Cell Biology|Cell Culture |
|||
Kanamycin (50mg/ml, 1000X) |
|||
| K2802-5 | ApexBio | 5x1ml | EUR 40 |
|
Description: Cell Biology|Cell Culture |
|||
MUG Supplement (50mg/vl) |
|||
| 26834 | Sisco Laboratories | 5 vl | EUR 16.25 |
|
Description: Part D |
|||
Timentin Solution, 50mg/mL |
|||
| 40110059-1 | Glycomatrix | 20 mL | EUR 23.8 |
Timentin Solution, 50mg/mL |
|||
| 40110059-2 | Glycomatrix | 50 mL | EUR 33.86 |
Timentin Solution, 50mg/mL |
|||
| 40110059-3 | Glycomatrix | 100 mL | EUR 44.84 |
Kanamycin solution (50mg/ml) |
|||
| MN800A-1 | SBI | 20 ml | EUR 75 |
Gentamicin Solution, 50mg/mL |
|||
| 25-533 | Genesee Scientific | 10 mL/Unit | EUR 19.67 |
|
Description: Sterile Solution |
|||
Ampicillin Solution 50mg/ml |
|||
| MBS651582-20mL | MyBiosource | 20mL | EUR 135 |
Ampicillin Solution 50mg/ml |
|||
| MBS651582-5x20mL | MyBiosource | 5x20mL | EUR 215 |
Cycloheximide Solution 50mg/ml |
|||
| MBS651240-20mL | MyBiosource | 20mL | EUR 195 |
Cycloheximide Solution 50mg/ml |
|||
| MBS651240-5x20mL | MyBiosource | 5x20mL | EUR 540 |
Lactobacilli Supplement (50mg/vl) |
|||
| 39785 | Sisco Laboratories | 5 vl | EUR 12.83 |
|
Description: Part D |
|||
Lactobacilli Supplement (50mg/vl) |
|||
| 39785-1 | Sisco Laboratories | 5 x5 vl | EUR 39.34 |
|
Description: Part D |
|||
50mg/mL G-418 Solution |
|||
| PB180125-10mL | Elabscience Biotech | 10 mL | EUR 55 |
|
Description: Supplements & Reagents |
|||
50mg/mL G-418 Solution |
|||
| PB180125 | Elabscience Biotech | 10mL | EUR 55 |
|
Description: Antibiotics |
|||
50mg/mL G-418 Solution |
|||
| MBS2567645-10mL | MyBiosource | 10mL | EUR 125 |
50mg/mL G-418 Solution |
|||
| MBS2567645-5x10mL | MyBiosource | 5x10mL | EUR 545 |
50mg Blasticidin S HCl - EACH |
|||
| 30-100-RB | Scientific Laboratory Supplies | EACH | EUR 260.55 |
G418 Sulfate, 50mg/mL, Sterile |
|||
| 40710027-1 | Glycomatrix | 20 mL | EUR 85.98 |
B.P. Sulpha Supplement (50mg/vl) |
|||
| 15097 | Sisco Laboratories | 5 vl | EUR 9.41 |
|
Description: Part D |
|||
50mg/mL Hygromycin B Solution |
|||
| PB180126-10mL | Elabscience Biotech | 10 mL | EUR 88 |
|
Description: Supplements & Reagents |
|||
50mg/mL Hygromycin B Solution |
|||
| PB180126 | Elabscience Biotech | 10mL | EUR 88 |
|
Description: Antibiotics |
|||
Protein A, Recombinant, 50mg/ml |
|||
| MBS638222-100mg | MyBiosource | 100mg | EUR 345 |
Protein A, Recombinant, 50mg/ml |
|||
| MBS638222-25mg | MyBiosource | 25mg | EUR 220 |
Protein A, Recombinant, 50mg/ml |
|||
| MBS638222-500mg | MyBiosource | 500mg | EUR 1205 |
Protein A, Recombinant, 50mg/ml |
|||
| MBS638222-5x500mg | MyBiosource | 5x500mg | EUR 5280 |
Hygromycin B 50mg/ml Solution |
|||
| MBS651334-10x1mL | MyBiosource | 10x1mL | EUR 395 |
Hygromycin B 50mg/ml Solution |
|||
| MBS651334-1mL | MyBiosource | 1mL | EUR 160 |
Hygromycin B 50mg/ml Solution |
|||
| MBS651334-5x1mL | MyBiosource | 5x1mL | EUR 285 |
50mg/mL Hygromycin B Solution |
|||
| MBS2570243-10mL | MyBiosource | 10mL | EUR 145 |
50mg/mL Hygromycin B Solution |
|||
| MBS2570243-5x10mL | MyBiosource | 5x10mL | EUR 635 |
Neomycin Sulfate Solution 50mg/ml |
|||
| MBS651502-20x20mL | MyBiosource | 20x20mL | EUR 530 |
Neomycin Sulfate Solution 50mg/ml |
|||
| MBS651502-5x20mL | MyBiosource | 5x20mL | EUR 195 |
Kanamycin Sulfate Solution(50mg/ml) |
|||
| 11981-04 | NACALAI TESQUE | 20ML | EUR 42 |
Perfringens Supplement-I (50mg/vl) |
|||
| 11976 | Sisco Laboratories | 5 vl | EUR 7.7 |
|
Description: Part D |
|||
Perfringens Supplement-I (50mg/vl) |
|||
| 11976-1 | Sisco Laboratories | 5 x5 vl | EUR 20.53 |
|
Description: Part D |
|||
Deoxyribonuclease I (DNase I), 50mg |
|||
| PC0704-50mg | Vivantis | each | Ask for price |
Kanamycin Sulfate 50mg/ml Solution |
|||
| MBS651522-10x20mL | MyBiosource | 10x20mL | EUR 345 |
Kanamycin Sulfate 50mg/ml Solution |
|||
| MBS651522-5x20mL | MyBiosource | 5x20mL | EUR 260 |
Gentamicin Sulfate Solution(50mg/ml) |
|||
| 11980-14 | NACALAI TESQUE | 10ML | EUR 56 |
Erythromycin Solution, 50mg/mL, Sterile |
|||
| 40120785-1 | Glycomatrix | 25 mL | EUR 24.71 |
Erythromycin Solution, 50mg/mL, Sterile |
|||
| 40120785-2 | Glycomatrix | 50 mL | EUR 39.35 |
Erythromycin Solution, 50mg/mL, Sterile |
|||
| 40120785-3 | Glycomatrix | 100 mL | EUR 72.29 |
Oxytetra Selective Supplement (50mg/vl) |
|||
| 51521 | Sisco Laboratories | 5 vl | EUR 7.7 |
|
Description: Part D |
|||
Oxytetra Selective Supplement (50mg/vl) |
|||
| 51521-1 | Sisco Laboratories | 5 x5 vl | EUR 24.8 |
|
Description: Part D |
|||
Chloramphenicol Solution, 50mg/mL, Sterile |
|||
| 40110067-1 | Glycomatrix | 10 mL | EUR 31.67 |
Chloramphenicol Solution, 50mg/mL, Sterile |
|||
| 40110067-2 | Glycomatrix | 25 mL | EUR 45.48 |
Bacteroides Selective Supplement (50mg/vl) |
|||
| 83141 | Sisco Laboratories | 5 vl | EUR 9.41 |
|
Description: Part D |
|||
Chloramphenicol Selective Supplement (50mg/vl) |
|||
| 14602 | Sisco Laboratories | 5 vl | EUR 9.41 |
|
Description: Part D |
|||
Chloramphenicol Selective Supplement (50mg/vl) |
|||
| 14602-1 | Sisco Laboratories | 5 x5 vl | EUR 27.37 |
|
Description: Part D |
|||
Cy3 Bis Nhs Ester 50Mg - EACH |
|||
| PA13002 | Scientific Laboratory Supplies | EACH | EUR 9913.05 |
Goat Anti-Mouse IgG Fc, 50MG |
|||
| A008-50MG | Arbor Assays | 50MG | EUR 1022.42 |
Goat Anti-Rabbit IgG Fc, 50MG |
|||
| A009-50MG | Arbor Assays | 50MG | EUR 1022.42 |
Wire Weight 50mg E2 Dakks - EACH |
|||
| YCW152102 | Scientific Laboratory Supplies | EACH | EUR 168.75 |
Hygromycin B Solution, 50mg/mL, Sterile |
|||
| 40810004-1 | Glycomatrix | 25 mL | EUR 80.99 |
Hygromycin B Solution, 50mg/mL, Sterile |
|||
| 40810004-2 | Glycomatrix | 50 mL | EUR 150.08 |
Neomycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40110068-1 | Glycomatrix | 10 mL | EUR 31.67 |
Neomycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40110068-2 | Glycomatrix | 25 mL | EUR 45.48 |
Kanamycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40110064-1 | Glycomatrix | 25 mL | EUR 31.57 |
Kanamycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40110064-2 | Glycomatrix | 50 mL | EUR 52.71 |
Kanamycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40110064-3 | Glycomatrix | 100 mL | EUR 73.01 |
Gentamicin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40710024-1 | Glycomatrix | 20 mL | EUR 44.92 |
Gentamicin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40710024-2 | Glycomatrix | 100 mL | EUR 112.16 |
Recombinant Bovine ATF Protein, Untagged, -50mg |
|||
| QP11095-50mg | EnQuireBio | 50mg | EUR 186 |
Streptomycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40121057-1 | Glycomatrix | 10 mL | EUR 12.81 |
Streptomycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40121057-2 | Glycomatrix | 25 mL | EUR 19.22 |
Streptomycin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40121057-3 | Glycomatrix | 50 mL | EUR 35.69 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-10x20mL | MyBiosource | 10x20mL | EUR 970 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-20mL | MyBiosource | 20mL | EUR 220 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-5x20mL | MyBiosource | 5x20mL | EUR 610 |
X-Gal Solution, 50mg/mL in DMF |
|||
| 21530036-1 | Glycomatrix | 2 mL | EUR 57.59 |
X-Gal Solution, 50mg/mL in DMF |
|||
| 21530036-2 | Glycomatrix | 5 mL | EUR 85.98 |
Spectinomycin Dihydrochloride Solution, 50mg/mL, Sterile |
|||
| 40121047-1 | Glycomatrix | 10 mL | EUR 26.54 |
Spectinomycin Dihydrochloride Solution, 50mg/mL, Sterile |
|||
| 40121047-2 | Glycomatrix | 25 mL | EUR 53.99 |
Spectinomycin Dihydrochloride Solution, 50mg/mL, Sterile |
|||
| 40121047-3 | Glycomatrix | 50 mL | EUR 89.68 |
C18(EC) 50mg/1mL SPE Columns - PK100 |
|||
| CHR5622 | Scientific Laboratory Supplies | PK100 | EUR 234.9 |
Standard Nitrile 50mg/L as N - 1L |
|||
| SDN0501 | Scientific Laboratory Supplies | 1L | EUR 443.58 |
Donkey Anti-Sheep IgG (H&L), 50MG |
|||
| A010-50MG | Arbor Assays | 50MG | EUR 1022.42 |
C18(EC) 50mg Fixed-well Plate - EACH |
|||
| CHR5624 | Scientific Laboratory Supplies | EACH | EUR 336.15 |
Amersham Cy5 Bis NHS ester 50mg - EACH |
|||
| PA15002 | Scientific Laboratory Supplies | EACH | EUR 7708.5 |
Amersham Cy5 mono NHS ester 50mg - EACH |
|||
| PA15102 | Scientific Laboratory Supplies | EACH | EUR 9413.55 |
Amersham Cy55 Bis NHS ester 50mg - EACH |
|||
| PA15502 | Scientific Laboratory Supplies | EACH | EUR 9478.35 |
Caffeine Standard 50mg/L in Water - 5ML |
|||
| CAFSTD50005 | Scientific Laboratory Supplies | 5ML | EUR 492.75 |
Ampicillin Sodium Salt Solution, 50mg/mL, Sterile |
|||
| 40120723-1 | Glycomatrix | 25 mL | EUR 35.21 |
Ampicillin Sodium Salt Solution, 50mg/mL, Sterile |
|||
| 40120723-2 | Glycomatrix | 50 mL | EUR 57.89 |
Ampicillin Sodium Salt Solution, 50mg/mL, Sterile |
|||
| 40120723-3 | Glycomatrix | 100 mL | EUR 76.66 |
Spectropho Pot Dichro A/T Std 50mg/L - 100ML |
|||
| RSPEC00201 | Scientific Laboratory Supplies | 100ML | EUR 286.2 |
Carbenicillin Disodium Salt Solution, 50mg/mL, Sterile |
|||
| 40120745-1 | Glycomatrix | 10 mL | EUR 17.39 |
Carbenicillin Disodium Salt Solution, 50mg/mL, Sterile |
|||
| 40120745-2 | Glycomatrix | 25 mL | EUR 26.54 |
Carbenicillin Disodium Salt Solution, 50mg/mL, Sterile |
|||
| 40120745-3 | Glycomatrix | 100 mL | EUR 61.8 |
Recombinant Multi Species ACTH Protein, Untagged, -50mg |
|||
| QP10950-50mg | EnQuireBio | 50mg | EUR 663.6 |
Peracetic Acid Indicator Strips 0-50mg/L - PK100 |
|||
| PAP1234 | Scientific Laboratory Supplies | PK100 | EUR 27 |
Alkalinity Std 50mg/L 50ppm as CaCO3 - 1L |
|||
| TA0501 | Scientific Laboratory Supplies | 1L | EUR 442.8 |
Spectinomycin Dihydrochloride Solution, 50mg/mL, Sterile Tubes |
|||
| 40121048-1 | Bio-WORLD | 25 tube(s) | Ask for price |
Spectinomycin Dihydrochloride Solution, 50mg/mL, Sterile Tubes |
|||
| 40121048-2 | Bio-WORLD | 50 tube(s) | Ask for price |
Kinesis TELOS QuEChERS Clean-up Kit Dispersive Pigmented Fruit and Veg; AOAC 2007.01; 150mg MgSO4 50mg PSA 50mg PestiCarb; 2ml - PK100 |
|||
| CHR6487 | Scientific Laboratory Supplies | PK100 | EUR 284.85 |
IC Anion Std Nitrate 50mg/L in H2O - 500ML |
|||
| ICAA04 | Scientific Laboratory Supplies | 500ML | EUR 132.19 |
IC Cation Std Ammonium 50mg/L in H2O - 500ML |
|||
| ICCA01 | Scientific Laboratory Supplies | 500ML | EUR 132.19 |
Ampicillin Sodium Salt Solution, 50mg/mL, Sterile Tubes |
|||
| 40120724-1 | Bio-WORLD | 25 tube(s) | Ask for price |
Ampicillin Sodium Salt Solution, 50mg/mL, Sterile Tubes |
|||
| 40120724-2 | Bio-WORLD | 50 tube(s) | Ask for price |
Ampicillin Sodium Salt Solution, 50mg/mL, Sterile Tubes |
|||
| 40120724-3 | Bio-WORLD | 100 tube(s) | Ask for price |
BioMag® Dextran-coated Charcoal Concentrate (50mg/ml) |
|||
| 84555-1 | Polysciences Europe GmbH | 1l | EUR 1759 |
G418 Sulfate (Geneticin) 50mg/ml Solution, Sterile-filtered |
|||
| MBS651498-20mL | MyBiosource | 20mL | EUR 195 |
G418 Sulfate (Geneticin) 50mg/ml Solution, Sterile-filtered |
|||
| MBS651498-5x20mL | MyBiosource | 5x20mL | EUR 555 |
Hygromycin B (HGR Solution), 50mg/ml in Aq. Solution |
|||
| 94663 | Sisco Laboratories | 20 ml | EUR 73.5 |
|
Description: Part B |
|||
OOMC00003-50MG - Astemizole |
|||
| OOMC00003-50MG | Aviva Systems Biology | 50mg | EUR 99 |
OOMC00007-50MG - Rapamycin |
|||
| OOMC00007-50MG | Aviva Systems Biology | 50mg | EUR 249 |
OOMC00025-50MG - Entacapone |
|||
| OOMC00025-50MG | Aviva Systems Biology | 50mg | EUR 159 |
OOMC00030-50MG - Valinomycin |
|||
| OOMC00030-50MG | Aviva Systems Biology | 50mg | EUR 189 |
OOMC00040-50MG - Ebselen |
|||
| OOMC00040-50MG | Aviva Systems Biology | 50mg | EUR 89 |
OOMC00042-50MG - Leflunomide |
|||
| OOMC00042-50MG | Aviva Systems Biology | 50mg | EUR 59 |
OOMC00043-50MG - Auranofin |
|||
| OOMC00043-50MG | Aviva Systems Biology | 50mg | EUR 69 |
OOMC00053-50MG - Omeprazole |
|||
| OOMC00053-50MG | Aviva Systems Biology | 50mg | EUR 59 |
OOMC00054-50MG - Emetine |
|||
| OOMC00054-50MG | Aviva Systems Biology | 50mg | EUR 69 |
OOMC00060-50MG - Tigecycline |
|||
| OOMC00060-50MG | Aviva Systems Biology | 50mg | EUR 269 |
OOMC00074-50MG - Umifenovir |
|||
| OOMC00074-50MG | Aviva Systems Biology | 50mg | EUR 249 |
OOMC00076-50MG - Ritonavir |
|||
| OOMC00076-50MG | Aviva Systems Biology | 50mg | EUR 199 |
OOMC00080-50MG - Nitazoxanide |
|||
| OOMC00080-50MG | Aviva Systems Biology | 50mg | EUR 199 |
OOMC00081-50MG - Trametinib |
|||
| OOMC00081-50MG | Aviva Systems Biology | 50mg | EUR 199 |
OOMC00088-50MG - Cepharanthine |
|||
| OOMC00088-50MG | Aviva Systems Biology | 50mg | EUR 59 |
OOAU00078-50MG - HPA |
|||
| OOAU00078-50MG | Aviva Systems Biology | 50mg | EUR 299 |
OOAU00085-50MG - Decitabine |
|||
| OOAU00085-50MG | Aviva Systems Biology | 50mg | EUR 539 |
OOAU00091-50MG - Xanthohumol |
|||
| OOAU00091-50MG | Aviva Systems Biology | 50mg | EUR 1049 |
Spectropho Pot Dichro A/T Std 50mg/L in Cuvs - PK2 |
|||
| RSPEC0020 | Scientific Laboratory Supplies | PK2 | EUR 1571.4 |
ICP Multi Elem (12) Tuning Std in 2% HNO3 50mg/L each - 100ML |
|||
| ICP12-50-100 | Scientific Laboratory Supplies | 100ML | EUR 550.8 |
Zymolyase 20T Concentrate 50mg/ml, 0.1M Sorbitol (Lyticase, Yeast Lytic Enzyme) |
|||
| MBS653686-1mL | MyBiosource | 1mL | EUR 185 |
Zymolyase 20T Concentrate 50mg/ml, 0.1M Sorbitol (Lyticase, Yeast Lytic Enzyme) |
|||
| MBS653686-5x1mL | MyBiosource | 5x1mL | EUR 395 |
OOMA00041-50MG - Sheep IgG |
|||
| OOMA00041-50MG | Aviva Systems Biology | 0.05g | EUR 259 |
OOMC00004-50MG - U-18666A |
|||
| OOMC00004-50MG | Aviva Systems Biology | 50mg | EUR 379 |
OOMC00005-50MG - Nafamostat mesylate |
|||
| OOMC00005-50MG | Aviva Systems Biology | 50mg | EUR 269 |
Results: 7 days pretreatments of L92 significantly reduced IAH-induced increase in intestinal permeability to FITC-dextran and histological damage (P <0.0001), accompanied by the suppression of inflammation and oxidative activation. Increased MCP-1 and IL-1β was significantly inhibited (P <0.05); anti-inflammatory cytokine, IL-4 and IL-10 were maintained at a high level; and oppression CAT (P <0.05) significantly reversed when pretreated with L92.
